Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
The Journal of Investigative Dermatology
|
October 15, 2018
Reduced-Intensity Conditioning Regimens, Prior Chronic Lymphocytic Leukemia, and Graft-Versus-Host Disease Are Associated with Higher Rates of Skin Cancer after Allogeneic Hematopoietic Stem Cell Transplantation
Peggy A Wu, Robert S Stern, Victor Huang, et al.
Acta Haematologica
|
February 14, 2015
Yttrium-90 ibritumomab tiuxetan followed by rituximab maintenance as treatment for patients with diffuse large B-cell lymphoma are not candidates for autologous stem cell transplant
Jon E Arnason, Katarina Luptakova, Jacalyn Rosenblatt, et al.
Nuclear Medicine Communications
|
July 31, 2014
Rifaximin suppresses background intestinal 18F-FDG uptake on PET/CT scans
Elisa Franquet, Mathew R Palmer, Anne E Gifford, et al.
Transfusion
|
May 1, 2024
High CD34-positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft-versus-host disease or mortality
Zachary M Avigan, Ajoy L Dias, Laura E Dodge, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 18, 2011
PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine
Jacalyn Rosenblatt, Brett Glotzbecker, Heidi Mills, et al.
Cancer Immunology, Immunotherapy : CII
|
June 27, 2012
Lenalidomide enhances anti-myeloma cellular immunity
Katarina Luptakova, Jacalyn Rosenblatt, Brett Glotzbecker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2007
Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248
Steven P Treon, Zachary R Hunter, Jeffrey Matous, et al.
Molecular Genetics & Genomic Medicine
|
October 6, 2015
Inherited CHST11/MIR3922 deletion is associated with a novel recessive syndrome presenting with skeletal malformation and malignant lymphoproliferative disease
Sameer S Chopra, Ignaty Leshchiner, Hatice Duzkale, et al.
Cancer Research
|
July 23, 2013
MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells
Dina Stroopinsky, Jacalyn Rosenblatt, Keisuke Ito, et al.
The New England Journal of Medicine
|
December 2, 2011
Interleukin-2 and regulatory T cells in graft-versus-host disease
John Koreth, Ken-ichi Matsuoka, Haesook T Kim, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
The Journal of Investigative Dermatology
|
October 15, 2018
Reduced-Intensity Conditioning Regimens, Prior Chronic Lymphocytic Leukemia, and Graft-Versus-Host Disease Are Associated with Higher Rates of Skin Cancer after Allogeneic Hematopoietic Stem Cell Transplantation
Peggy A Wu, Robert S Stern, Victor Huang, et al.
Acta Haematologica
|
February 14, 2015
Yttrium-90 ibritumomab tiuxetan followed by rituximab maintenance as treatment for patients with diffuse large B-cell lymphoma are not candidates for autologous stem cell transplant
Jon E Arnason, Katarina Luptakova, Jacalyn Rosenblatt, et al.
Nuclear Medicine Communications
|
July 31, 2014
Rifaximin suppresses background intestinal 18F-FDG uptake on PET/CT scans
Elisa Franquet, Mathew R Palmer, Anne E Gifford, et al.
Transfusion
|
May 1, 2024
High CD34-positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft-versus-host disease or mortality
Zachary M Avigan, Ajoy L Dias, Laura E Dodge, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 18, 2011
PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine
Jacalyn Rosenblatt, Brett Glotzbecker, Heidi Mills, et al.
Cancer Immunology, Immunotherapy : CII
|
June 27, 2012
Lenalidomide enhances anti-myeloma cellular immunity
Katarina Luptakova, Jacalyn Rosenblatt, Brett Glotzbecker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2007
Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248
Steven P Treon, Zachary R Hunter, Jeffrey Matous, et al.
Molecular Genetics & Genomic Medicine
|
October 6, 2015
Inherited CHST11/MIR3922 deletion is associated with a novel recessive syndrome presenting with skeletal malformation and malignant lymphoproliferative disease
Sameer S Chopra, Ignaty Leshchiner, Hatice Duzkale, et al.
Cancer Research
|
July 23, 2013
MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells
Dina Stroopinsky, Jacalyn Rosenblatt, Keisuke Ito, et al.
The New England Journal of Medicine
|
December 2, 2011
Interleukin-2 and regulatory T cells in graft-versus-host disease
John Koreth, Ken-ichi Matsuoka, Haesook T Kim, et al.
Page
of 3